Kilitch Drugs (India) Limited has informed the Exchange regarding submission of Letter of Offer in connection with Proposed Rights Issue of the Fully Paid up Equity Shares in terms of Regulation 71(2) of SEBI(Issue of Capital and Disclosure Requirements) Regulation 2018
KILITCH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kilitch Drugs (India) Limited has submitted the Letter of Offer to the stock exchanges for its proposed Rights Issue of 13,98,463 fully paid-up equity shares of face value Rs. 10 each. The issue price is set at Rs. 357 per share (including a premium of Rs. 347), aggregating to approximately Rs. 49.93 crores on a rights basis. Eligible shareholders can subscribe in the ratio of 2 rights shares for every 23 fully paid-up shares held as on the record date of July 15, 2025. The issue opens on July 23, 2025 and closes on August 21, 2025, with listing on BSE and NSE expected on August 26, 2025. The company has already received in-principle approvals from both stock exchanges for listing the rights shares.
Existing shareholders need to evaluate and act on the rights entitlement before August 21, 2025. If fully subscribed, the share count will rise by roughly 8.7%, causing moderate dilution. Non-subscribing shareholders will see their effective stake reduced unless they sell their rights entitlements in the market.